NCT07694440 — "A Study of MZE782 in Adults With PKU" trial site landscape

Public-registry site landscape for NCT07694440, “A Study of MZE782 in Adults With PKU”, a Phenylketonuria (PKU) study sponsored by Maze Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07694440 (registry record)
Study title	A Study of MZE782 in Adults With PKU
Official title	A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety, Tolerability, and Efficacy of MZE782 in Adults With Phenylketonuria (PKU)
Sponsor	Maze Therapeutics
Condition(s)	Phenylketonuria (PKU)
Phase	PHASE2
Listed sites	1
Intervention(s)	MZE782
Site countries	United States

Patient-friendly overview of this study: eichor.com/study/NCT07694440.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07694440 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →